SCHEMBL1765158

SCHEMBL1765158

Cc1ccccc1-c1ccccc1C=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.67
ALDH1A1 P00352 2/20 0.67
MEN1 O00255 1/20 0.52
LMNA P02545 1/20 0.52
THRB P10828 1/20 0.52
BLM P54132 1/20 0.52
KMT2A Q03164 1/20 0.52
TDP1 Q9NUW8 1/20 0.52
TRIM24 O15164 2/20 0.44
TRIM33 Q9UPN9 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2C19 P33261 1/20 0.44
NR1H2 P55055 1/20 0.41
NR1H3 Q13133 1/20 0.41
BRD4 O60885 1/20 0.40
KCNN4 O15554 1/20 0.40
ACHE P22303 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5711185 0.93 TSHR (0.58) TSHRALDH1A1MEN1LMNATHRB
Benzaldehyde SCHEMBL28137222 0.90 ALDH1A1 (0.55) TSHRALDH1A1MEN1LMNATHRB
SCHEMBL3932855 0.85 ALDH1A1 (0.59) TSHRALDH1A1MEN1LMNATHRB
SCHEMBL1830923 0.85 ALDH1A1 (0.59) TSHRALDH1A1MEN1LMNATHRB
SCHEMBL30340593 0.85 ALDH1A1 (0.59) TSHRALDH1A1MEN1LMNATHRB
SCHEMBL31175932 0.85 KMT2A (0.71) TSHRALDH1A1MEN1LMNATHRB
SCHEMBL249552 0.85 KMT2A (0.71) TSHRALDH1A1MEN1LMNATHRB
SCHEMBL29186211 0.84 ALDH1A1 (0.57) TSHRALDH1A1MEN1LMNATHRB
SCHEMBL1669198 0.84 ALDH1A1 (0.57) TSHRALDH1A1MEN1LMNATHRB
SCHEMBL1666568 0.84 ALDH1A1 (0.57) TSHRALDH1A1MEN1LMNATHRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114082446-B Chiral zirconium catalyst for preparing chiral alpha-hydroxy-beta-keto ester compound and preparation method thereof 南开沧州渤海新区绿色化工研究有限公司 2023-12-22 CN disclosed
CN-114082446-A Chiral zirconium catalyst for preparing chiral alpha-hydroxy-beta-keto ester compound and preparation method thereof 南开沧州渤海新区绿色化工研究有限公司 2022-02-25 CN disclosed
CN-106660971-B Dual inhibitor compounds for use in the treatment of neurodegenerative diseases and alzheimer's disease 意大利学院科技基金会 2020-10-13 CN disclosed
US-10351506-B2 Purified plasticizers, production and use EXXONMOBIL CHEMICAL PATENTS INC. (US) 2019-07-16 US disclosed
US-20190031593-A1 Purified Plasticizers, Production and Use EXXONMOBIL CHEMICAL PATENTS INC. 2019-01-31 US disclosed
US-9944618-B2 Inhibiting neurotransmitter reuptake MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2018-04-17 US disclosed
US-20160024044-A1 INHIBITING NEUROTRANSMITTER REUPTAKE MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH 2016-01-28 US disclosed
EP-2504324-B1 SULTAM DERIVATIVES HOFFMANN LA ROCHE (CH) 2015-02-25 EP disclosed
US-8883796-B2 Biphenyl derivatives, pharmaceutical composition comprising the same, and preparation method thereof KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-11-11 US disclosed
WO-2014159251-A2 INHIBITING NEUROTRANSMITTER REUPTAKE MAYO FOUNDATION FOR MEDICAL EDUCATION AND RESEARCH (US) 2014-10-02 WO disclosed
EP-0239423-B1 Positive type radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO LTD (JP) 1996-03-20 EP disclosed
EP-0342635-B1 Azacyclic carboxylic acid derivatives, their preparation and use NOVO NORDISK AS (DK) 1994-08-17 EP disclosed
US-5087548-A POSITIVE TYPE RADIATION-SENSITIVE RESIN COMPOSITION JAPAN SYNTHETIC RUBBER CO., INC. (JP) 1992-02-11 US disclosed
CN-1055927-A Benzimidazole derivatives, their preparation and use TAKEDA CHEMICAL INDUSTRIES LTD (JP) 1991-11-06 CN disclosed
US-5019479-A Photoresists for integrated circuits JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1991-05-28 US disclosed
EP-0342635-A1 Azacyclic carboxylic acid derivatives, their preparation and use NOVO NORDISK A/S (DK) 1989-11-23 EP disclosed
EP-0239423-A2 Positive type radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1987-09-30 EP disclosed
EP-0227487-A2 Positive type radiation-sensitive resin composition JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1987-07-01 EP disclosed
US-4192824-A CARBONYL COMPOUNDS PROVIDE RING CLOSURE OF POLYCYCLIC COMPOUNDS COAL INDUSTRY (PATENTS) LIMITED (GB) 1980-03-11 US disclosed
US-4137259-A SILVER VANADATE, IRON VANADATE STAMICARBON, B.V. (NL) 1979-01-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10351506-B2 Purified plasticizers, production and use ALKBH3, FTO, ALK TSHR 2624/4885ALDH1A1 142/4885MEN1 3330/4885
US-20190031593-A1 Purified Plasticizers, Production and Use ALKBH3, FTO, ALK TSHR 2624/4885ALDH1A1 142/4885MEN1 3330/4885
US-20160024044-A1 INHIBITING NEUROTRANSMITTER REUPTAKE SLC6A2, SLC18A2, SLC6A4 TSHR 652/4885ALDH1A1 173/4885MEN1 880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.